C

Caidya

Global CRO delivering end-to-end clinical development

Project Specialist

Full-TimeUpdated on 10/24/2026
No salary listed
Junior
Bachelor's
Remote in China
RemoteAbility to work remotely; minimal travel may be required (10%).
Biology & BiotechClinical Research Operations

About the job

Requirements
  • At least 1 year of experience in the clinical research industry is required.
  • Prior relevant work experience with clinical systems such as CTMS, eTMF, or EDC is required.
  • Experience with the clinical research process and terminology is required.
  • Strong written and verbal communication skills in English and the local language are required.
  • Working knowledge of ICH/GCP guidelines is required.
  • Problem-solving skills are required.
  • Computer literacy, including working knowledge of PCs, Windows, and Microsoft Office applications, is required.
  • Advanced Excel skills are required.
  • A university degree is preferred; a healthcare or life science degree is a plus. Equivalent education and relevant work experience may be considered, with a minimum of 3 years of work experience in the absence of a degree.
  • Ability to work remotely is required.
  • Ability to work effectively and efficiently, in a dynamic and changing environment, is required.
  • Honesty, trust, fairness, cooperation, self-control, and flexibility are expected.
  • Minimal travel may be required, approximately 10%.
Responsibilities
  • Administer system access, conduct ongoing access surveillance, and revoke access when needed.
  • Support the Project Manager or Project Director in setting up and maintaining the MSP study timeline and team reporting timelines.
  • Create and deploy study-specific training matrices, ensure team compliance with assigned training, document training, and escalate non-compliance.
  • Coordinate and support preparation of the Executive Monthly Report, and obtain and maintain study progress reports and trackers.
  • Review analytics and reports from Clarity Insight, identify missing data, and determine follow-up actions.
  • Support the Project Manager and work directly with the project team to keep source systems current.
  • Maintain the project server and portal, where applicable.
  • Organize and participate in kickoff meetings for internal and sponsor study teams, as applicable.
  • Support project team meetings by coordinating agendas and recording minutes, decisions, and action items for sponsor and internal meetings, as applicable.
  • Organize and finalize presentation materials for investigator, internal, client, and departmental meetings.
  • Track outstanding actions from project meetings through completion.
  • Coordinate cross-functional financial units and milestone reporting.
  • Maintain the out-of-scope tracker.
  • Support site payments and associated tracking as needed; work with Grants Administration to process investigator or site payments and draft amended site budget templates, as applicable.
  • At study closure, support the Project Manager or Project Director with final reconciliation of sponsor, vendor, and site payments, as applicable.
  • Support and coordinate the setup and maintenance of functional plans, project-specific procedures, guidelines, documents, and forms with the project team.
  • Work with the Project Manager or Project Director to develop and distribute timesheet guidelines for project teams and support team training on them.
  • Work with the Project Manager or Project Director to maintain the list of standard operating procedures implemented on the project, if applicable.
  • Set up and maintain study working files using core study-specific templates.
  • Support the project team in managing audits and resolving Corrective Action Plan Agreements, as applicable.
  • Provide general administrative support to the Project Manager or Project Director, including formatting, compiling slides, and circulating documents for review.
  • Follow up, track, and transcribe laboratory normal ranges as outlined in CMG-436-GL.
  • Conduct work in accordance with standard operating procedures, policies and practices, good clinical practices, and applicable regulatory requirements, meeting quality and timeline metrics.
  • At study closure, support Medical Writing and the Project Manager with collation of Clinical Study Report appendices, where applicable.
  • At study closure, support the Project Manager or Project Director in ensuring the CTMS system is closed out according to requirements.
  • Perform other duties as required by the department or delegated by the Project Manager or Project Director, and support department needs as assigned.
Desired Qualifications
  • A healthcare or life science degree is a plus.

About the company

Caidya is a global contract research organization that provides outsourced clinical development services for biopharmaceutical and medical device companies. It covers the full lifecycle from pre-IND strategy and early-phase development through late-stage trials, regulatory submissions, and post-marketing surveillance, delivered via flexible models like standalone projects, full-service partnerships, and functional service provider arrangements, supported by its Clarity data platform that offers near real-time trial visibility and compatibility with Medidata Rave and Veeva. Its competitive edge comes from the merged legacy of Clinipace and dMed Global, strong leadership under Dr. Lingshi Tan, a broad global footprint including North America and China, and an emphasis on data-driven, transparent trial delivery. The goal is to help clients bring therapies to market efficiently and compliantly through high-quality, scalable trial execution across global programs.

Company Size

201-500

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$322.2M

Headquarters

Morrisville, North Carolina

Founded

2003

Get referred to Caidya

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 NMPA accepted partner MediLink's Tam-Peli NDA, validating China execution.
  • Caidya’s APAC-heavy model fits sponsors needing China speed and regulatory navigation.
  • Rubicon’s $165 million 2025 growth capital still funds expansion and integration.

What critics are saying

  • Combining Caidya and Simbec-Orion creates integration failure risk through 2026-2027.
  • CRO rivals Fortrea, ICON, and Medpace outspend Caidya on scale and technology.
  • Failed integration traps Caidya as a subscale CRO and forces retrenchment.

What makes Caidya unique

  • June 30, 2026 deal with Simbec-Orion adds Phase I clinical pharmacology to Caidya.
  • Barbara Lopez Kunz now runs a CRO spanning Europe, Americas, APAC, and China.
  • Michael Clay’s February 2026 COO hire deepens global delivery across 60 countries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

-1%

2 year growth

-1%
Business Wire
Jul 1st, 2026
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution....

Associated Press
Feb 17th, 2026
Caidya appoints Michael Clay as COO to strengthen global clinical trial operations across Asia-Pacific

Caidya, a global clinical research organisation, has appointed Michael Clay as chief operating officer. Clay will oversee global operational delivery, client engagement and execution strategy across the US, Europe and Asia-Pacific. Clay brings extensive experience leading global clinical programmes across more than 60 countries, with particular expertise in Asia-Pacific operations. Most recently, he served as senior vice president of Global Project Delivery at Fortrea, where he managed over 500 global clinical trials. The appointment strengthens Caidya's operational capabilities, particularly in China and the broader APAC region. Caidya operates in more than 20 countries and conducts studies across over 50 countries, focusing on complex therapeutic areas including oncology, haematology and rare diseases.

Business Wire
Jan 16th, 2025
Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders

Caidya today announced the closing of a strategic growth investment of $165 million from funds managed by Rubicon Founders.

Business Wire
Jan 13th, 2025
Caidya Announces $165 Million Strategic Growth Investment From Rubicon Founders

Caidya announces $165 million strategic growth investment from Rubicon Founders.

FinSMEs
Jul 10th, 2021
dMed-Clinipace Closes US$50M Series C+ Financing

dMed-Clinipace, a Shangai, China- and Morrisville, NC-based global full-service Clinical Contract Research Organization (CRO), closed a US$50m Series C+ financing. The round was led by Springhill Fund, with participation from funds managed by Rock Springs Capital and Superstring Capital. They joined Series C lead investor Fidelity Management and Research Company LLC as well as other new […]